J Park, CH Cheon - The Journal of Organic Chemistry, 2022 - ACS Publications
A concise total synthesis of rucaparib, an FDA-approved drug for ovarian and prostate
cancers, is reported. The Heck reaction of the commercially available aryl iodide with …